Cargando…
Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy
We present a follow-up case report of a 33-year-old lady with juvenile onset arthritis who developed halo naevi while on treatment with tocilizumab. This case report describes the development of halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy following infection...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979291/ https://www.ncbi.nlm.nih.gov/pubmed/27516894 http://dx.doi.org/10.1093/omcr/omw027 |